Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report, By Type (Innovative APIs Generic APIs), By Type of Drug (Prescription, Over the Counter), By Potency (Traditional APIs, High Potency APIs) By Region, Forecasts, 2024-2031

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Active Pharmaceutical Ingredients Market Snapshot
Chapter 4. Global Active Pharmaceutical Ingredients Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. By Type, & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type:
5.2.1. Innovative APIs
5.2.2. Generic APIs
Chapter 6. Market Segmentation 2: By Synthesis Estimates & Trend Analysis
6.1. By Synthesis & Market Share, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Synthesis:

6.2.1. Synthetic APIs
6.2.2. Innovative Synthetic APIs
6.2.2.1. Generic Synthetic APIs
6.2.3. Biotech APIs
6.2.3.1. By Type
6.2.3.1.1. Innovative Biotech APIs
6.2.3.1.2. Generic Biotech APIs
6.2.3.2. By Product
6.2.3.2.1. Monoclonal Antibodies
6.2.3.2.2. Hormones and Growth Factors
6.2.3.2.3. Fusion proteins
6.2.3.2.4. Cytokines
6.2.3.2.5. Therapeutic enzymes
6.2.3.2.6. Blood factors and Anti-coagulants
6.2.3.2.7. Recombinant vaccines
6.2.3.3. By Expression Systems
6.2.3.3.1. Mammalian expression systems
6.2.3.3.2. Microbial expression systems
6.2.3.3.3. Yeast expression systems
6.2.3.3.4. Insect expression systems
6.2.3.3.5. Other expression system

Chapter 7. Market Segmentation 3: By Type of Drug Estimates & Trend Analysis
7.1. By Type of Drug & Market Share, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type of Drug:

7.2.1. Prescription
7.2.2. Over the Counter

Chapter 8. Market Segmentation 4: By Potency Estimates & Trend Analysis
8.1. By Potency & Market Share, 2023 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Potency:

8.2.1. Traditional APIs
8.2.2. High Potency APIs

Chapter 9. Market Segmentation 5: By End-User Estimates & Trend Analysis
9.1. By End-User & Market Share, 2023 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-User:

9.2.1. Pharmaceutical & Biotechnology Industry
9.2.2. Contract Research Organization
9.2.3. Contract manufacturing Organization
9.2.4. Others

Chapter 10. Active Pharmaceutical Ingredients Market Segmentation 6: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By Type, 2024-2031
10.1.2. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By Synthesis, 2024-2031
10.1.3. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By Type of Drug, 2024-2031
10.1.4. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By Potency, 2024-2031
10.1.5. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
10.1.6. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts by country, 2024-2031

10.2. Europe

10.2.1. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type, 2024-2031
10.2.2. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By Synthesis, 2024-2031
10.2.3. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type of Drug, 2024-2031
10.2.4. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By Potency, 2024-2031
10.2.5. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By End-User, 2024-2031
10.2.6. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) by country, 2024-2031

10.3. Asia Pacific

10.3.1. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type, 2024-2031
10.3.2. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By Synthesis, 2024-2031
10.3.3. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type of Drug, 2024-2031
10.3.4. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By Potency, 2024-2031
10.3.5. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By End-User, 2024-2031
10.3.6. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) by country, 2024-2031

10.4. Latin America

10.4.1. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type, (US$ Million) 2024-2031
10.4.2. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By Synthesis, (US$ Million) 2024-2031
10.4.3. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type of Drug, (US$ Million) 2024-2031
10.4.4. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By Potency, (US$ Million) 2024-2031
10.4.5. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By End-User, (US$ Million) 2024-2031
10.4.6. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) by country, 2024-2031

10.5. Middle East & Africa

10.5.1. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type, (US$ Million) 2024-2031
10.5.2. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By Synthesis, (US$ Million) 2024-2031
10.5.3. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type of Drug, (US$ Million) 2024-2031
10.5.4. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By Potency, (US$ Million) 2024-2031
10.5.5. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By End-User, (US$ Million) 2024-2031
10.5.6. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) by country, 2024-2031

Chapter 11. Competitive Landscape

11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles

11.2.1. UPL
11.2.2. Pfizer Inc.
11.2.3. Teva Pharmaceutical Industries Ltd.
11.2.4. GSK PLC
11.2.5. Sanofi
11.2.6. Viatris Inc.
11.2.7. Divi's Laboratories Limited
11.2.8. Sandoz Group AG
11.2.9. Boehringer Ingelheim International Gmbh
11.2.10. Sk Inc.
11.2.11. Eli Lilly And Company
11.2.12. Merck Kgaa
11.2.13. Abbvie Inc.
11.2.14. F. Hoffmann-La Roche Ltd.
11.2.15. Astrazeneca
11.2.16. Dr. Reddy’s Laboratories Ltd.
11.2.17. Sun Pharmaceutical Industries Ltd.
11.2.18. Cipla
11.2.19. Evonik Industries Ag
11.2.20. Hikma Pharmaceuticals Plc
11.2.21. BASF SE
11.2.22. Alembic Pharmaceuticals Limited
11.2.23. Other Prominent Players

Segmentation of Active Pharmaceutical Ingredients Market-

Active Pharmaceutical Ingredients Market- By Type

• Innovative APIs
• Generic APIs

Active Pharmaceutical Ingredients Market- By Synthesis

• Synthetic APIs
• Innovative Synthetic APIs

• Generic Synthetic APIs

• Biotech APIs

• By Type
• Innovative Biotech APIs
• Generic Biotech APIs
• By Product
• Monoclonal Antibodies
• Hormones and Growth Factors
• Fusion proteins
• Cytokines
• Therapeutic enzymes
• Blood factors and Anti-coagulants
• Recombinant vaccines
• By Expression Systems
• Mammalian expression systems
• Microbial expression systems
• Yeast expression systems
• Insect expression systems
• Other expression system

Active Pharmaceutical Ingredients Market- By Type of Drug

• Prescription
• Over the Counter

Active Pharmaceutical Ingredients Market- By Potency

• Traditional APIs
• High Potency APIs

Active Pharmaceutical Ingredients Market- By End User

• Pharmaceutical & Biotechnology Industry
• Contract Research Organization
• Contract manufacturing Organization
• Others

Active Pharmaceutical Ingredients Market By Region-

North America-

• The US
• Canada
• Mexico

Europe-

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-

• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Rest of Latin America

 Middle East & Africa-

• GCC Countries
• South Africa
• Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

• Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
• External and internal proprietary databases, regulatory databases, and relevant patent analysis
• Statistical databases, National government documents, and market reports
• Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

• Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
• Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
• Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
• End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.